BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8536738)

  • 21. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Macheta MP; Parapia LA; Gouldesbrough DR
    J Clin Pathol; 1995 Feb; 48(2):181-2. PubMed ID: 7745121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
    Mulligan SP; Dean MG
    Aust N Z J Med; 1994 Aug; 24(4):406-7. PubMed ID: 7980241
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatal fludarabine-induced extensive bone marrow necrosis in a patient with chronic lymphocytic leukemia.
    Braester A; Elmalah Y; Quitt M
    Leuk Lymphoma; 2003 Oct; 44(10):1835-6. PubMed ID: 14692545
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
    Montalban C; Liaño F; Aguilera A
    Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment].
    Bauduer F
    Presse Med; 2009 Jan; 38(1):140-2. PubMed ID: 19004611
    [No Abstract]   [Full Text] [Related]  

  • 27. Evans syndrome complicating fludarabine treatment for advanced B-CLL.
    Shvidel L; Shtarlid M; Klepfish A; Sigler E; Berrebi A
    Br J Haematol; 1997 Dec; 99(3):706. PubMed ID: 9401088
    [No Abstract]   [Full Text] [Related]  

  • 28. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ; Orchard JA; Myint H; Oscier DG
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract]   [Full Text] [Related]  

  • 29. Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.
    Sezer O; Schmid P; Hallek M; Schweigert M; Beinert T; Langelotz C; Mergenthaler HG; Possinger K
    Ann Hematol; 1999 Oct; 78(10):475-7. PubMed ID: 10550560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.
    Coso D; Costello R; Cohen-Valensi R; Sainty D; Nezri M; Gastaut JA; Bouabdallah R
    Ann Oncol; 1999 Mar; 10(3):362-3. PubMed ID: 10355587
    [No Abstract]   [Full Text] [Related]  

  • 31. Paradoxical exacerbation of psoriasis during therapy with fludarabine.
    Jordan J; Mey U; Bieber T; Wilsmann-Theis D
    Eur J Dermatol; 2008; 18(3):365-6. PubMed ID: 18474491
    [No Abstract]   [Full Text] [Related]  

  • 32. Fludarabine-induced eosinophilia: case report.
    Voutsadakis IA
    Ann Hematol; 2002 May; 81(5):292-3. PubMed ID: 12029541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia.
    Cohen RB; Abdallah JM; Gray JR; Foss F
    Ann Intern Med; 1993 Jan; 118(2):114-6. PubMed ID: 8416307
    [No Abstract]   [Full Text] [Related]  

  • 34. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
    Hocepied AM; Falkson CI; Falkson G
    S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine].
    Kuliszkiewicz-Janus M; Małecki R; Kuliczkowski K; Jeleń M
    Pol Arch Med Wewn; 2002 Sep; 108(3):887-91. PubMed ID: 12600186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
    Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fludarabine and fatal hemolytic anemia].
    López L; del Villar V; Pascual T
    Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
    [No Abstract]   [Full Text] [Related]  

  • 38. Two views of the immunologic effects of fludarabine.
    Schilling PJ
    Oncology (Williston Park); 1991 Feb; 5(2):12. PubMed ID: 1672596
    [No Abstract]   [Full Text] [Related]  

  • 39. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic strategies to meet infectious complications in fludarabine-treated CLL.
    Südhoff T; Arning M; Schneider W
    Leukemia; 1997 Apr; 11 Suppl 2():S38-41. PubMed ID: 9178837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.